Natural PAK1 inhibitors: potent anti-inflammatory effectors for prevention of pulmonary fibrosis in COVID-19 therapy

References

• Abdul-Hammed M, Adedotun IO, Olajide M, Irabor CO, Afolabi TI, Gbadebo IO, Rhyman L, Ramasami P. 2022. Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (Mpro). Nat Prod Res. 36(12):3110–3116. doi: 10.1080/14786419.2021.1935933.
   PubMed Web of Science ®Google Scholar
• Alesci A, Aragona M, Cicero N, Lauriano ER. 2022. Can nutraceuticals assist treatment and improve COVİD-19 symptoms? Nat Prod Res. 36(10):2672–2691. doi: 10.1080/14786419.2021.1914032.
   PubMed Web of Science ®Google Scholar
• Arias-Romero LE, Chernoff J. 2008. A tale of two paks. Biol Cell. 100(2):97–108. doi: 10.1042/BC20070109.
   PubMed Web of Science ®Google Scholar
• Arslan I, Akgul H, Kara M. 2021. Saporin, a polynucleotide–adenosine nucleosidase, may be an efficacious therapeutic agent for SARS-CoV-2 ınfection. SLAS Discov. 26(3):330–335. doi: 10.1177/2472555220970911.
   PubMed Web of Science ®Google Scholar
• Arslan I, Cenzano AM. 2020. N-triterpene saponins in cancer therapy: a review of mode of action. Rev Bras Farmacogn. 30(1):1–6. doi: 10.1007/s43450-020-00033-5.
   Google Scholar
• Arslan I, Cenzano AM. 2021. Characterization of triterpene saponins from Gypsophila arrostii by electrospray ıonization ıon trap multiple-stage mass spectrometry. Rev Bras Farmacogn. 31(1):107–111. doi: 10.1007/s43450-021-00125-w.
   Google Scholar
• Attoub S, Arafat K, Gélaude A, Al Sultan MA, Bracke M, Collin P, Takahashi T, Adrian TE, De Wever O. 2013. Frondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis. PLoS One. 8(1):e53087. doi: 10.1371/journal.pone.0053087.
   PubMed Web of Science ®Google Scholar
• Batra A, Warren CM, Ke Y, McCann M, Halas M, Capote AE, Liew CW, Solaro RJ, Rosas PC. 2021. Deletion of P21-activated kinase-1 induces age-dependent increased visceral adiposity and cardiac dysfunction in female mice. Mol Cell Biochem. 476(3):1337–1349. doi: 10.1007/s11010-020-03993-3.
   PubMed Web of Science ®Google Scholar
• Berretta AA, Silveira MAD, Capcha JMC, De Jong D. 2020. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease. Biomed Pharmacother. 131:110622. doi: 10.1016/j.biopha.2020.110622.
   PubMed Web of Science ®Google Scholar
• Cai XZ, Wang J, Li XD, Wang GL, Liu FN, Cheng MS, Li F. 2009. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Biol Ther. 8(14):1360–8. doi: 10.4161/cbt.8.14.8720.
   Google Scholar
• Chen I-Y, Chang SC, Wu H-Y, Yu T-C, Wei W-C, Lin S, Chien C-L, Chang M-F. 2010. Upregulation of the chemokine (CC motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway. J Virol. 84(15):7703–7712. doi: 10.1128/JVI.02560-09.
   PubMed Web of Science ®Google Scholar
• Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. 2020 March-April. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 34(2):327–331. doi: 10.23812/CONTI-E.
   PubMed Web of Science ®Google Scholar
• Demestre M, Messerli SM, Celli N, Shahhossini M, Kluwe L, Mautner V, Maruta H. 2009. CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice. Phytother Res. 23(2):226–230. doi: 10.1002/ptr.2594.
   PubMed Web of Science ®Google Scholar
• Duderstadt EL, McQuaide SA, Sanders MA, Samuelson DJ. 2021. Chemical carcinogen-induced rat mammary carcinogenesis is a potential model of p21-activated kinase positive female breast cancer. Physiol Genomics. 53(2):61–68. doi: 10.1152/physiolgenomics.00112.2020.
   PubMed Web of Science ®Google Scholar
• El-Hawary SS, Issa MY, Ebrahim HS, Mohammed AF, Hayallah AM, El-Kadder EMA, Sayed AM, Abdelmohsen UR. 2022. Potential of (Citrus nobilis Lour × Citrus deliciosa Tenora) metabolites on COVID-19 virus main protease supported by in silico analysis. Nat Prod Res. 36(11):2843–2847. doi: 10.1080/14786419.2021.1917573.
   PubMed Web of Science ®Google Scholar
• Foryst-Ludwig A, Naumann M. 2000. p21-activated kinase 1 activates the nuclear factor kappaB (NFkappaB)-inducing kinase-IkappaB kinases NFkappaB pathway and proinflammatory cytokines in Helicobacter pylori infection. J Biol Chem. 275:3.
   Google Scholar
• Hedin U, Daum G, Clowes AW. 1998. Heparin inhibits thrombininduced mitogen-activated protein kinase signaling in arterial smooth muscle cells. J Vasc Surg. 27(3):512–520. doi: 10.1016/s0741-5214(98)70326-x.
   PubMed Web of Science ®Google Scholar
• Hippensteel JA, LaRiviere WB, Colbert JF, Langouët-Astrié CJ, Schmidt EP. 2020. Heparin as a therapy for COVID-19: current evidence and future possibilities. Am J Physiol Lung Cell Mol Physiol. 319(2):L211–L217. doi: 10.1152/ajplung.00199.2020.
   PubMed Web of Science ®Google Scholar
• Hufendiek P, Stölben SSM, Kehraus S, Merten N, Harms H, Crüsemann M, Arslan I, Gütschow M, Schneider T, König GM., 2017. Biosynthetic studies on acetosellin and structure elucidation of a new acetosellin derivative. Planta Med. 83(12–13):1044–1052. doi: 10.1055/s-0042-124493.
   PubMed Web of Science ®Google Scholar
• Hussein G, Sankawa U, Goto H, Matsumoto K, Watanabe H. 2006. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod. 69(3):443–449. doi: 10.1021/np050354+.
   PubMed Web of Science ®Google Scholar
• Jin W, Zhang W, Mitra D, McCandless MG, Sharma P, Tandon R, Zhang F, Linhardt RJ.,. 2020. The structureactivity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica. Int J Biol Macromol. 163:1649–1658. doi: 10.1016/j.ijbiomac.2020.09.184.
   PubMed Web of Science ®Google Scholar
• Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M. 1987. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun. 142(2):436–440. doi: 10.1016/0006-291x(87)90293-2.
   PubMed Web of Science ®Google Scholar
• Kimoto T, Arai S, Kohguchi M, Aga M, Nomura Y, Micallef MJ, Kurimoto M, Mito K. 1998. Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis. Cancer Detect Prev. 22(6):506–515. doi: 10.1046/j.1525-1500.1998.00020.x.
   PubMedGoogle Scholar
• Knaus UG, Morris S, Dong H, Chernoff J, Bokoch G. 1995. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science. 269(5221):221–223. doi: 10.1126/science.7618083.
   PubMed Web of Science ®Google Scholar
• Kumar R, Gururaj AE, Barnes CJ. 2006. p21-activated kinases in cancer. Nat Rev Cancer. 6(6):459–471. doi: 10.1038/nrc1892.
   PubMed Web of Science ®Google Scholar
• Kumar A, Molli PR, Pakala SB, Bui Nguyen TM, Rayala SK, Kumar R. 2009. PAK thread from amoeba to mammals. J Cell Biochem. 107(4):579–585. doi: 10.1002/jcb.22159.
   PubMed Web of Science ®Google Scholar
• Lee W-S, Chen R-J, Wang Y-J, Tseng H, Jeng J-H, Lin S-Y, Liang Y-C, Chen C-H, Lin C-H, Lin J-K, et al. 2003. In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: g 0/G1 p53-associated cell cycle arrest. Int J Cancer. 106(1):125–137. doi: 10.1002/ijc.11194.
   PubMed Web of Science ®Google Scholar
• Li DQ, Nair SS, Ohshiro K, Kumar A, Nair VS, Pakala SB, Reddy SDN, Gajula RP, Eswaran J, Aravind L, et al. 2012. MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response. Cell Rep. 2(6):1657–1669. doi: 10.1016/j.celrep.2012.11.018.
   PubMed Web of Science ®Google Scholar
• Liu W, Zi M, Naumann R, Ulm S, Jin J, Taglieri DM, Prehar S, Gui J, Tsui H, Xiao RP, Neyses L, Solaro RJ, Ke Y, Cartwright EJ, Lei M, Wang X. 2011 Dec. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation. 13(124):2702–15. doi: 10.1161/CIRCULATIONAHA.111.048785.
   Google Scholar
• Lu S, Strand, KA, Mutryn MF, Tucker RM, Jolly AJ, Furgeson SB, Moulton KS, Nemenoff RA, Weiser-Evans MCM. 2020. PTEN (phosphatase and tensin homolog) protects against Ang II (Angiotensin II)-induced pathological vascular fibrosis and remodeling—brief report. Arterioscler Thromb Vasc Biol. 40(2):394–403. doi: 10.1161/ATVBAHA.119.313757.
   PubMed Web of Science ®Google Scholar
• Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L. 1994. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature. 367(6458):40–46. doi: 10.1038/367040a0.
   PubMed Web of Science ®Google Scholar
• Maruta H. 2021. Marine Pak1-blockers for therapy of Covid-19. NAPDD. 5(4):555667. doi: 10.19080/NAPDD.2021.05.555667.
   Google Scholar
• Maruta H, He H. 2020. PAK1-blockers: potential therapeutics against COVID-19. Med Drug Discov. 6:100039. doi: 10.1016/j.medidd.2020.100039.
   PubMedGoogle Scholar
• Maruta H, Kittaka A. 2020. Chemical evolution for taming the ‘pathogenic kinase’PAK1. Drug Discov Today. 25(6):959–964. doi: 10.1016/j.drudis.2020.03.008.
   PubMed Web of Science ®Google Scholar
• Messerli SM, Ahn MR, Kunimasa K, Yanagihara M, Tatefuji T, Hashimoto K, Mautner V, Uto Y, Hori H, Kumazawa S, et al. 2009. Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1 signaling and suppresses the growth of NF tumors in mice. Phytother Res. 23(3):423–427. doi: 10.1002/ptr.2658.
   PubMed Web of Science ®Google Scholar
• Nandi S, Ahmed S, Saxena A, Saxena AK. 2023. Exploring the pathoprofiles of SARS-COV-2 ınfected human gut–lungs microbiome crosstalks. In: Kothari V, Kumar P, Ray S, editors. Probiotics, Prebiotics, Synbiotics, and Postbiotics. Springer, Singapore. doi: 10.1007/978-981-99-1463-0_12.
   Google Scholar
• Nandi S, Kumar M, Saxena M, Saxena AK. 2021a. The antiviral and antimalarial drug repurposing in quest of chemotherapeutics to combat COVID-19 utilizing structure-based molecular docking. Comb Chem High Throughput Screen. 24(7):1055–1068. doi: 10.2174/1386207323999200824115536.
   PubMed Web of Science ®Google Scholar
• Nandi S, Nayak BS, Khede MK, Saxena AK. 2022. Repurposing of chemotherapeutics to combat Covid-19. Curr Top Med Chem. 22(32):2660–2694. doi: 10.2174/1568026623666221130142517.
   PubMed Web of Science ®Google Scholar
• Nandi S, Roy H, Gummadi A, Saxena AK. 2021b. Exploring spike protein as potential target of novel coronavirus and to ınhibit the viability utilizing natural agents. Curr Drug Targets. 22(17):2006–2020. doi: 10.2174/1389450122666210309105820.
   PubMed Web of Science ®Google Scholar
• Nguyen BCQ, Yoshimura K, Kumazawa S, Tawata S, Maruta H. 2017. Frondoside A from sea cucumber and nymphaeols from Okinawa propolis: natural anti-cancer agents that selectively inhibit PAK1 in vitro. Drug Discov Ther. 11(2):110–114. doi: 10.5582/ddt.2017.01011.
   PubMedGoogle Scholar
• Nheu TV, He H, Hirokawa Y, Tamaki K, Florin L, Schmitz ML, Suzuki-Takahashi I, Jorissen RN, Burgess AW, Nishimura S, et al. 2002. The K252a derivatives, inhibitors for the PAK/MLK kinase family, selectively block the growth of HAS transformants. Cancer J. 8(4):328–336. doi: 10.1097/00130404-200207000-00009.
   PubMed Web of Science ®Google Scholar
• Nheu T, He H, Hirokawa Y, Walker F, Wood J, Maruta H. 2004. PAK is essential for RAS-induced upregulation of cyclin D1 during the G1 to S transition. Cell Cycle. 3(1):70–73. doi: 10.4161/cc.3.1.593.
   Web of Science ®Google Scholar
• Pillaiyar T, Laufer S. 2022. Kinases as potential therapeutic targets for anti-coronaviral therapy. J Med Chem. 65(2):955–982. doi: 10.1021/acs.jmedchem.1c00335.
   PubMed Web of Science ®Google Scholar
• Reddy SDN, Ohshiro K, Rayala SK, Kumar R. 2008. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its function. Cancer Res. 68(20):8195–8200. doi: 10.1158/0008-5472.CAN-08-2103.
   PubMed Web of Science ®Google Scholar
• Shahinozzaman M, Basak B, Emran R, Rozario P, Obanda DN. 2020. Artepillin C: a comprehensive review of its chemistry, bioavailability, and pharmacological properties. Fitoterapia. 147:104775. doi: 10.1016/j.fitote.2020.104775.
   PubMed Web of Science ®Google Scholar
• Sherr CJ. 1995. D-type cyclins. Trends Biochem Sci. 20(5):187–190. doi: 10.1016/s0968-0004(00)89005-2.
   PubMed Web of Science ®Google Scholar
• Shimada S. 1969. Antifungal steroid glycoside from sea cucumber. Science. 163(3874):1462–1462. doi: 10.1126/science.163.3874.1462.
   PubMed Web of Science ®Google Scholar
• Taira N, Nguyen BCQ, Be Tu PT, Tawata S. 2016. Effect of Okinawa Propolis on PAK1 activity, Caenorhabditis elegans longevity, melanogenesis, and growth of cancer cells. J Agric Food Chem. 64(27):5484–5489. doi: 10.1021/acs.jafc.6b01785.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Nguyen BCQ, Uto Y, Shahinozzaman M, Tawata S, Maruta H. 2017. 2, 3-Triazolyl esterization of PAK1-blocking propolis ingredients, artepillin C (ARC) and caffeic acid (CA), for boosting their anti-cancer/anti-PAK1 activities along with cell-permeability. Drug Discov Ther. 11(2):104–109. doi: 10.5582/ddt.2017.01009.
   PubMed Web of Science ®Google Scholar
• Teo M, Manser E, Lim L. 1995. Identification and molecular cloning of a p21cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J Biol Chem. 270(44):26690–26697. doi: 10.1074/jbc.270.44.26690.
   PubMed Web of Science ®Google Scholar
• Thangapazham RL, Sharma A, Maheshwari RK. 2006. Multiple molecular targets in cancer chemoprevention by curcumin. Aaps J. 8(3):E443–E449. doi: 10.1208/aapsj080352.
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Kumar R. 2003. P21-activated kinases in human cancer. Cancer Metastasis Rev. 22(4):385–393. doi: 10.1023/a:1023729130497.
   PubMed Web of Science ®Google Scholar
• Wang WX, Zhang YR, Luo SY, Zhang YS, Zhang Y, Tang C. 2022. Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking. Nat Prod Res. 36(10):2580–2584. doi: 10.1080/14786419.2021.1904923.
   PubMed Web of Science ®Google Scholar
• WHO. 2023. WHO press conference on global health issues. [Maria Van Kerkhove]: We are in the fourth year of this pandemic and the virus is circulating and people are getting reinfected. [accessed 2023 Jun 7]. www.who.int.
   Google Scholar
• Yanase S, Luo Y, Maruta H. 2013. PAK1-deficiency/down-regulation reduces brood size, activates HSP16. 2 gene and extends lifespan in Caenorhabditis elegans. Drug Discov Ther. 7(1):29–35. doi: 10.5582/ddt.2013.v7.1.29.
   PubMedGoogle Scholar
• Yazaki K, Yoshikoshi C, Oshiro S, Yanase S. 2011. Supplemental cellular protection by a carotenoid extends lifespan via Ins/IGF-1 signaling in Caenorhabditis elegans. Oxid Med Cell Longev. 2011:596240–596249. doi: 10.1155/2011/596240.
   PubMed Web of Science ®Google Scholar
• Yun S-H, Sim E-H, Han S-H, Han J-Y, Kim S-H, Silchenko AS, Stonik VA, Park J-I. 2018. Holotoxin A1 induces apoptosis by activating acid sphingomyelinase and neutral sphingomyelinase in K562 and human primary leukemia cells. Mar Drugs. 16(4):123. doi: 10.3390/md16040123.
   PubMed Web of Science ®Google Scholar
• Zaim S, Chong JH, Sankaranarayanan V, Harky A. 2020. COVID-19 and multiorgan response. Curr Probl Cardiol. 45(8):100618. doi: 10.1016/j.cpcardiol.2020.100618.
   PubMed Web of Science ®Google Scholar